6/4/2025

GE Healthcare has seen increasing demand based on the aging population trend. Click here to read why GEHC stock is attractive for patient investors.

Source: SeekingAlpha

6/3/2025

GE Healthcare Technologies Inc: * GE HEALTHCARE: FILES FOR OFFERING OF $650 MILLION 4.800%SENIORNOTES DUE 2031 - SEC FILING * GE HEALTHCARE: FILES FOR OFFERING OF $850...

Source: Finnhub

6/3/2025

GE HealthCare Technologies Inc. stock rises Tuesday, outperforms market

Source: MarketWatch

6/3/2025

You don't have permission to access http://www.gehealthcare.com/about/newsroom/press-releases/kalbe-and-gehealthcare-launch-indonesias-first-ct-scanner-production-facility on this server. ...

Source: Finnhub

6/2/2025

PharmaLogic Holdings Corp. ("PharmaLogic" or "the Company"), a leading contract development and manufacturing organization (CDMO) specialized in radiopharmaceuticals, today announces the Company has appointed Etienne Montagut, currently serving as President, to the position of President and Chief Executive Officer, effective as of 1 June 2025.

Source: Yahoo

6/2/2025

ARLINGTON HEIGHTS - GE HealthCare announced that the NCCN Clinical Practice Guidelines in Oncology for clinicians now recommend considering fluoroestradiol positron emission tomography for...

Source: Finnhub

6/2/2025

ARLINGTON HEIGHTS, Ill. - GE HealthCare today announced that the NCCN Clinical Practice Guidelines in Oncology )for clinicians now recommend considering fluoroestradiol positron emission tomography ...

Source: Finnhub

5/30/2025

GE HealthCare Technologies Inc. stock falls Friday, underperforms market

Source: MarketWatch

5/30/2025

ARLINGTON HEIGHTS, Ill., May 30, 2025--GE HealthCare announced that the NCCN Guidelines for Clinical Oncology now recommend FES PET for systemic staging in patients with metastatic ILC.

Source: Yahoo

5/30/2025

GE HealthCare announced that the NCCN Clinical Practice Guidelines in Oncology for clinicians now recommend considering fluoroestradiol positron emission tomography for systemic staging in patients...

Source: Finnhub

5/21/2025

GE HealthCare Technologies Inc. stock falls Wednesday, underperforms market

Source: MarketWatch

5/21/2025

It is hard to get excited after looking at GE HealthCare Technologies' (NASDAQ:GEHC) recent performance, when its stock...

Source: Yahoo

5/20/2025

GE HealthCare Technologies Inc. stock falls Tuesday, underperforms market

Source: MarketWatch

5/16/2025

Key Insights Significantly high institutional ownership implies GE HealthCare Technologies' stock price is sensitive to...

Source: Yahoo

5/15/2025

CHICAGO, May 15, 2025--GE HealthCare (Nasdaq: GEHC) today announced the launch of CleaRecon DL, technology powered by a deep-learning algorithm, to improve the quality of cone-beam computed tomography (CBCT) images. This artificial intelligence (AI)-driven solution is designed to remove streak artifacts caused by the pulsatile nature of blood flow in the arteries and changes in the distribution of contrast during CBCT acquisitions in liver, prostate, neuro, and endovascular aortic repair procedu

Source: Yahoo

5/15/2025

GE HealthCare Technologies Inc. announced the launch of CleaRecon DL, technology powered by a deep-learning algorithm, to improve the quality of cone-beam computed tomography images. This artificial...

Source: Finnhub

5/14/2025

GE HealthCare (GEHC) announced the FDA has approved a pediatric indication for its Optison ultrasound enhancing agent. This approval will help improve the clarity of echocardiograms for diagnosing heart conditions in pediatric patients, enhancing the assessment of ventricular function. Optison, the only PEG-free UEA available in the U.S., was first approved for adult use in 1997. Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>> See I

Source: Yahoo

5/14/2025

This article provides a top-down analysis of the healthcare sector using value, quality, and momentum metrics. Read the full analysis here on Seeking Alpha, updated for May 2025.

Source: SeekingAlpha

5/13/2025

ARLINGTON HEIGHTS, Ill., May 13, 2025--GE HealthCare (Nasdaq: GEHC) today announced the U.S. Food and Drug Administration (FDA) has approved a pediatric indication for the company’s Optison™ (Perflutren Protein-Type A Microspheres Injectable Suspension, USP) ultrasound enhancing agent (UEA). This approval will help improve the clarity and diagnostic accuracy of echocardiograms in pediatric patients, giving cardiologists a fuller picture of ventricular function when assessing possible heart abnor

Source: Yahoo

5/13/2025

CHICAGO & SAN RAMON, Calif., May 13, 2025--GE HealthCare (Nasdaq: GEHC) and Raydiant Oximetry, Inc. today announced a joint development initiative to enhance fetal monitoring capabilities that could strengthen the support of clinical decision-making during labor. This effort leverages the combined expertise and technology of the two companies to advance fetal oxygen saturation monitoring technology with the goal of enhancing the detection of fetal distress during childbirth.

Source: Yahoo